Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal

  • Slides: 27
Download presentation
Treatment Guidelines for Pre-operative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International

Treatment Guidelines for Pre-operative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel EH Baldini, D Wang, CN Catton, DJ Indelicato, DG Kirsch, C Deville, C Le Pechoux, R Haas, IA Petersen, K May, D Roberge, BA Guadagnolo, B O'Sullivan, R Abrams, TF De. Laney

None of the authors have disclosures

None of the authors have disclosures

Background • The role of RT for extremity soft tissue sarcoma is well established

Background • The role of RT for extremity soft tissue sarcoma is well established • However, the role of RT for retroperitoneal sarcoma (RPS) is unproven

EORTC 62092 -22092 (STRASS Trial) RPS: Randomize Pre-Op RT Surgery Ongoing, results are eagerly

EORTC 62092 -22092 (STRASS Trial) RPS: Randomize Pre-Op RT Surgery Ongoing, results are eagerly anticipated

Background • In the meantime, many centers recommend Pre-op RT for RPS after multidisciplinary

Background • In the meantime, many centers recommend Pre-op RT for RPS after multidisciplinary discussion • But, there are no RT guidelines for this approach

Purpose • To define radiation treatment guidelines for Pre-operative RT for RPS

Purpose • To define radiation treatment guidelines for Pre-operative RT for RPS

RT Treatment Nomenclature • GTV: Gross Tumor Volume • CTV: Clinical Target Volume –

RT Treatment Nomenclature • GTV: Gross Tumor Volume • CTV: Clinical Target Volume – Expansion of GTV to include areas at risk for harboring potential microscopic disease • PTV: Planning Target Volume – Expansion of CTV to account for daily patient set-up inaccuracies and/or patient movement • Treatment Field Borders – Extend beyond the PTV by about 7 mm to deliver full dose to PTV

Extremity Soft Tissue Sarcoma RT Treatment Guidelines* CTV • GTV + 4 cm proximal/distal,

Extremity Soft Tissue Sarcoma RT Treatment Guidelines* CTV • GTV + 4 cm proximal/distal, • 1. 5 cm radial • Edit CTV at bone PTV • CTV + 5 -10 mm per institutional standard *Haas, IJROBP 84: 572; 2012 4 cm 1. 5 cm GTV: red CTV: green PTV: orange

GTV, CTV, PTV Note the CTV is edited at the bone interface

GTV, CTV, PTV Note the CTV is edited at the bone interface

GTV CTV Expansions Vary by Tumor Lymphoma Prostate Cancer Lung Cancer GTV CTV Expansion

GTV CTV Expansions Vary by Tumor Lymphoma Prostate Cancer Lung Cancer GTV CTV Expansion 0 mm 5 -7 mm Glioblastoma Multiforme 2 cm beyond edema Extremity STS 1. 5 cm radial 4 cm proximal/distal ? Retroperitoneal Sarcoma

Methods • An expert panel of 15 academic radiation oncologists who specialize in sarcoma

Methods • An expert panel of 15 academic radiation oncologists who specialize in sarcoma was convened • Panel members reached consensus recommendations following several meetings, conference calls and email correspondence

Expert Panel: US Institutions (10) • • • Dana-Farber/Brigham & Women’s Hospital Massachusetts General

Expert Panel: US Institutions (10) • • • Dana-Farber/Brigham & Women’s Hospital Massachusetts General Hospital Medical College of Wisconsin University of Florida, Jacksonville Duke University of Pennsylvania Mayo Clinic Roswell Park Cancer Institute MD Anderson Cancer Center Rush University

Expert Panel: European and Canadian Institutions (4) Canada – Princess Margaret Cancer Centre –

Expert Panel: European and Canadian Institutions (4) Canada – Princess Margaret Cancer Centre – Mc. Gill University Health Centre France – Institut Gustave Roussy Netherlands – Netherlands Cancer Institute

Results Consensus Recommendations

Results Consensus Recommendations

Essential Collaboration between Surgeon + Radiation Oncologist Discuss resection margins of concern Discuss potential

Essential Collaboration between Surgeon + Radiation Oncologist Discuss resection margins of concern Discuss potential resection of kidney, liver – If nephrectomy is planned: » Adequate contra-lateral renal function should be documented » Minimize dose to contra-lateral kidney – If partial liver resection is planned: » Minimize dose to remaining liver

Radiation Simulation • Oral and IV contrast is optional • Assessment of 4 D

Radiation Simulation • Oral and IV contrast is optional • Assessment of 4 D motion (4 D CT) – Strongly recommended for tumors above iliac crest to define GTV 4 D • Contour GTV on the planning CT – Register planning CT with diagnostic CT or MR T 1 contrast images if necessary

CTV Definition Expand GTV symmetrically by 1. 5 cm Edit CTV: • • •

CTV Definition Expand GTV symmetrically by 1. 5 cm Edit CTV: • • • Bone: 0 mm Bowel and Air Cavity: 5 mm Renal and Hepatic interfaces: 2 mm Skin Surface: 3 -5 mm If tumor extends through inguinal canal, add 3 cm distally (as per extremity STS) • If 4 D CT is not performed, larger expansions are necessary for upper abdominal tumors

PTV Definition • Expand CTV by 5 mm – If frequent volumetric soft tissue

PTV Definition • Expand CTV by 5 mm – If frequent volumetric soft tissue imaging will be performed to confirm set-up accuracy (i. e. cone beam CT) • Expand CTV by 9 -12 mm – If no volumetric imaging is performed to confirm set-up

Dose 5040 c. Gy 180 c. Gy fractions 5 ½ weeks

Dose 5040 c. Gy 180 c. Gy fractions 5 ½ weeks

RPS Contours GTV CTV PTV

RPS Contours GTV CTV PTV

RPS IMRT Graphic Plan Iso-dose Levels 100% 70% 95% 50% 80% 30%

RPS IMRT Graphic Plan Iso-dose Levels 100% 70% 95% 50% 80% 30%

Dose-Painting Radiation Boost to High Risk Margins CONCEPT: • Deliver boost dose of RT

Dose-Painting Radiation Boost to High Risk Margins CONCEPT: • Deliver boost dose of RT to areas of tumor at risk for positive margins after resection • Along posterior abdominal wall, pre-vertebral space, major vessels GTV High Risk Boost Volume

Dose-Painting Radiation Boost to High Risk Margins • Efficacy is unproven • Technique is

Dose-Painting Radiation Boost to High Risk Margins • Efficacy is unproven • Technique is under investigation • May be considered, particularly on protocol – De. Laney Phase I/II Multi-Center Dose. Painting Boost, Dose-Escalation Trial

Organ at Risk (OAR) Constraints ORGAN CONSTRAINT Liver Mean Dose < 26 Gy Stomach

Organ at Risk (OAR) Constraints ORGAN CONSTRAINT Liver Mean Dose < 26 Gy Stomach and Duodenum V 45<100%, V 50<50%, Max 56 Gy Kidney: if one will be resected V 18 < 15% remaining kidney Kidney: if both will remain Mean dose < 15 Gy, V 18 < 50% Spinal Cord Max Dose 50 Gy Small & Large Bowel (Bowel Bag) V 45 < 195 cc Rectum V 50 < 50% Testicles V 3 < 50%, Max Dose < 18 Gy Ovary Max Dose < 3 Gy Femoral Head Max Dose < 50 Gy, V 40 < 64%

Treatment Technique • Intensity modulated radiation therapy (IMRT) preferred unless OAR constraints can be

Treatment Technique • Intensity modulated radiation therapy (IMRT) preferred unless OAR constraints can be met with 3 D-conformal technique

Conclusion • Consensus guidelines were achieved and are recommended for use –To establish uniformity

Conclusion • Consensus guidelines were achieved and are recommended for use –To establish uniformity of treatment –Aid future efficacy and toxicity assessment

Thank You • • Tom De. Laney Dian Wang Charles Catton Danny Indelicato David

Thank You • • Tom De. Laney Dian Wang Charles Catton Danny Indelicato David Kirsch Curt Deville Cecile Le Pechoux • • Rick Haas Ivy Petersen Kilian May David Roberge Ashleigh Guadagnolo Brian O’Sullivan Ross Abrams